CYTENA
Dr. Jamin J. has a diverse work experience in the biopharma industry. Dr. Jamin currently works at CYTENA as a Sales Executive, where they are responsible for selling biosciences technologies to scientists and lab technicians. Prior to that, they worked at Nanolive SA as a Technical Sales Specialist. Dr. Jamin also has experience in advanced training in Life Science Management at ATV Ausbildung Training Vernetzung GmbH. Dr. Jamin J. started their career as a Postdoctoral Researcher at Institut Pasteur, where they worked from 2015 to 2018.
Dr. Jamin J. began their education at Technische Universität Darmstadt in 2004, where they pursued a degree in Biology/Biological Sciences, General. Dr. Jamin completed this program in 2009, earning a Diplom degree. In 2009, Dr. J. enrolled in The Julius Maximilians University of Würzburg, where they pursued a Ph.D. in Cell/Cellular and Molecular Biology. Dr. Jamin successfully completed their Ph.D. program in 2015. Additionally, during their Ph.D. studies, they served as a visiting scientist at the International Centre of Insect Physiology and Ecology for a brief period in 2011.
CYTENA
cytena GmbH has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated imaging process to encapsulate cells indroplets, which are delivered to any type of substrate. Thanks to this particularly gentle delivery method, the cells are able to survive post printing and can either be analyzed thereafter or grown into clonal colonies. To determine clonality, multiple images are recorded during the process. Cross-contamination is avoided by the use of disposable parts.